Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Statistics

Total Valuation

SGMO has a market cap or net worth of $362.30 million. The enterprise value is $363.61 million.

Market Cap	362.30M
Enterprise Value	363.61M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

SGMO has 208.22 million shares outstanding. The number of shares has increased by 11.58% in one year.

Shares Outstanding	208.22M
Shares Change (YoY)	+11.58%
Shares Change (QoQ)	+13.09%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	35.49%
Float	189.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.33
Forward PS	7.72
PB Ratio	15.29
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	29.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 1.23.

Current Ratio	1.03
Quick Ratio	0.73
Debt / Equity	1.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -194.05% and return on invested capital (ROIC) is -75.50%.

Return on Equity (ROE)	-194.05%
Return on Assets (ROA)	-58.29%
Return on Capital (ROIC)	-75.50%
Revenue Per Employee	$30,314
Profits Per Employee	-$616,481
Employee Count	405
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, SGMO has paid $1.17 million in taxes.

Income Tax	1.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +278.26% in the last 52 weeks. The beta is 1.10, so SGMO's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+278.26%
50-Day Moving Average	1.02
200-Day Moving Average	0.74
Relative Strength Index (RSI)	64.44
Average Volume (20 Days)	11,974,210

Short Selling Information

The latest short interest is 18.22 million, so 8.75% of the outstanding shares have been sold short.

Short Interest	18.22M
Short Previous Month	18.16M
Short % of Shares Out	8.75%
Short % of Float	9.61%
Short Ratio (days to cover)	7.21

Income Statement

In the last 12 months, SGMO had revenue of $12.28 million and -$249.68 million in losses. Loss per share was -$1.35.

Revenue	12.28M
Gross Profit	-146.93M
Operating Income	-194.96M
Pretax Income	-248.51M
Net Income	-249.68M
EBITDA	-184.99M
EBIT	-194.96M
Loss Per Share	-$1.35

Balance Sheet

The company has $27.79 million in cash and $29.10 million in debt, giving a net cash position of -$1.31 million or -$0.01 per share.

Cash & Cash Equivalents	27.79M
Total Debt	29.10M
Net Cash	-1.31M
Net Cash Per Share	-$0.01
Equity (Book Value)	23.69M
Book Value Per Share	0.11
Working Capital	1.07M

Cash Flow

In the last 12 months, operating cash flow was -$173.38 million and capital expenditures -$5.42 million, giving a free cash flow of -$178.79 million.

Operating Cash Flow	-173.38M
Capital Expenditures	-5.42M
Free Cash Flow	-178.79M
FCF Per Share	-$0.86

Margins

Gross Margin	n/a
Operating Margin	-1,588.02%
Pretax Margin	-2,024.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,456.32%

Dividends & Yields

SGMO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.58%
Shareholder Yield	-11.58%
Earnings Yield	-68.91%
FCF Yield	-49.35%

Analyst Forecast

The average price target for SGMO is $2.67, which is 53.45% higher than the current price. The consensus rating is "Buy".

Price Target	$2.67
Price Target Difference	53.45%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	13.92%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGMO has an Altman Z-Score of -28.12 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.12
Piotroski F-Score	1